Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Venous Thrombosis × Dalteparin × Clear all

Phase

Phase 3 5 Phase 2 2 Phase NA 1 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Classical hematology 1

Conditions

Venous Thrombosis 1 Venous Thromboembolism 1 Thromboembolism 1 Thrombocytopenia 1 Pulmonary Embolism 1 Pancreatic Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Hemorrhage 1

Interventions

edoxaban 1 apixaban 1 Rivaroxaban 1 Heparin, Low-Molecular-Weight 1 Fluorodeoxyglucose F18 1 Dalteparin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00966277 2016-12-12

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

M.D. Anderson Cancer Center

Phase 4 Completed

87 enrolled 9 charts

Classical hematologyGastrointestinal

Pancreatic Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡